Short CommunicationSpecies Difference in the Contribution of T-Type Calcium Current to Cardiac Pacemaking as Revealed by R(−)-EFONIDIPINE (cas 111011-63-3)
-
Add time:08/30/2019 Source:sciencedirect.com
The contribution of the T-type Ca2+ current to cardiac pacemaking was examined in isolated right atrial tissue from the mouse, guinea pig, and rabbit using a specific blocker, R(−)-efonidipine. At 10−6 M, R(-)-efonidipine produced negative chronotropy, which was prominent in the mouse and small but significant in the guinea pig. No effect was observed in the rabbit. Microelectrode recordings revealed that R(-)-efonidipine significantly prolongs the pacemaker (phase 4) depolarization of the sinoatrial-node action potential in the mouse and guinea pig. These results provide the first pharmacological evidence that the contribution of T-type Ca2+ current to cardiac pacemaking differs among experimental animal species.
We also recommend Trading Suppliers and Manufacturers of EFONIDIPINE (cas 111011-63-3). Pls Click Website Link as below: cas 111011-63-3 suppliers
Prev:Original contributionEffect of EFONIDIPINE (cas 111011-63-3) and ACE inhibitors on proteinuria in human hypertension with renal impairment
Next:General PapersEffects of the Antihypertensive Drug Efonidipine Hydrochloride (cas 111011-79-1) on Albuminuria and Renal Histopathology in Young Spontaneously Hypertensive Rats with Diabetes) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original contributionEffect of EFONIDIPINE (cas 111011-63-3) and ACE inhibitors on proteinuria in human hypertension with renal impairment08/29/2019
- Full PaperEffect of EFONIDIPINE (cas 111011-63-3) on TGF-β1–Induced Cardiac Fibrosis Through Smad2-Dependent Pathway in Rat Cardiac Fibroblasts08/28/2019
- Cardiovascular PharmacologyEffects of S(+)-EFONIDIPINE (cas 111011-63-3) on the rabbit sinus node action potential and calcium channel subunits CaV1.2, CaV1.3 and CaV3.108/27/2019
- Effects of the iron chelator deferiprone and the T-type calcium channel blocker EFONIDIPINE (cas 111011-63-3) on cardiac function and Ca2+ regulation in iron-overloaded thalassemic mice08/26/2019
- The Ca2 + channel inhibitor EFONIDIPINE (cas 111011-63-3) decreases voltage-dependent K+ channel activity in rabbit coronary arterial smooth muscle cells08/25/2019
- A chiral LC–MS/MS method for the stereospecific determination of EFONIDIPINE (cas 111011-63-3) in human plasma08/24/2019
- Determination of EFONIDIPINE (cas 111011-63-3) in human plasma by LC–MS/MS for pharmacokinetic applications08/23/2019
- Research paperIncreased bioavailability of EFONIDIPINE (cas 111011-63-3) hydrochloride nanosuspensions by the wet-milling method08/22/2019


